DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans. - Wikidata - awgldk - TriplyDB

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

http://www.wikidata.org/entity/Q34187707

about

The Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western Countries Overview of the Pathogenesis of ANCA-Associated Vasculitis PTPN22 R620W polymorphism and ANCA disease risk in white populations: a metaanalysis Pathogenesis of ANCA-associated vasculitis Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.Pathogenesis of ANCA-associated vasculitis.Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'.Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.Genetically determined severity of anti-myeloperoxidase glomerulonephritis.Granulomatosis with polyangiitis in childhood.Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?B cell-mediated pathogenesis of ANCA-mediated vasculitis.Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis.Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis.Granulomatosis with polyangiitis according to geographic origin and ethnicity: clinical-biological presentation and outcome in a French population.The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey.The epidemiology of ANCA associated vasculitis in Olmsted County, Minnesota (USA): a 20 year population-based study.HLA-DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Cohort Study.Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis.Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model.Pathophysiological lessons from rare associations of autoimmune diseases.

P2860

Q26740451-863FCA91-FFBC-4CC9-AE8E-669C80F3F494 Q26740456-95675F9D-D439-4AD3-8EFA-518D86B66AC7 Q28387197-78F441CA-FE33-4946-AFE1-24F7F339B653 Q28390438-D42111C9-4F1F-4C35-9F94-F621F63B6146 Q33862188-09AC69A2-7B21-42FF-931E-57287F9C7A8D Q34296337-D9373852-7407-4BB9-8393-04264BC84603 Q35695000-A53186ED-EF4F-4A2C-B3AC-8571CD48891E Q36104863-1529B554-89F6-4EB2-8DF3-F552120CEE13 Q36750119-572B1117-A13C-4D82-B525-A0C71DCF7943 Q37979678-E9129FE7-36AC-41C7-ADA7-2E372EE9960D Q38100780-292087C5-18FE-4272-B42B-4A46872EB872 Q38204971-B0DBEAE7-A4B3-44D4-9F2C-8CDC89EBE4FB Q38207938-E380EAF2-D6E3-467C-8F0D-D9772EB4F820 Q38227267-50E0A1F6-227B-431A-A6CB-380AE4B9B9E5 Q38293706-9B79014E-7432-49B0-A53E-6F9CD653F655 Q38389842-816D8273-B10C-4613-A6D4-D40EEA73DE0E Q38512570-D4D2FE7B-6421-42FC-8894-19CBC3C049B2 Q39518123-8DE97811-A749-43F5-9BBE-BE989F5FDB3C Q39907297-9E6DE91D-02CC-4119-AFD8-879D91FFB07D Q40053425-870B4905-A9B7-43D6-8B68-ACCFDF541FF4 Q46055267-94FFCF8D-B302-4D65-ABE6-87612F278B32 Q47714730-F2CBAD89-465E-4721-BD9D-7AFF87F36955 Q49408761-6E4B28CE-72C2-4E7E-8B7E-0ABDDB6A3269 Q50350312-592CF7C3-6B71-4429-AF52-2EF569452372

P2860

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

http://www.wikidata.org/entity/Q34187707

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

@ast

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

@en

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

@nl

type

label

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

@ast

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

@en

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

@nl

prefLabel

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

@ast

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

@en

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

@nl

P1433

Q34187707-F278D153-0233-45D5-8E2C-E23074CE75F5

P1476

Q34187707-7EA44BE6-A8EB-42F5-9414-5A0CECEEE2F4

P2093

Q34187707-01BD3CF6-9D13-4D4A-9277-EA1AADDBC8A6

Q34187707-055C7836-C5FC-4E88-A9B1-0DDE838E3D01

Q34187707-346AFEA0-1BFE-40AE-A87B-0E32E8C47B60

Q34187707-3A570709-92BB-424D-8286-183BD167226D

Q34187707-45AFF654-79D1-4DBE-B404-BB6A5E97A655

Q34187707-51A0E62D-CE20-41D2-BC65-5335EE06910F

Q34187707-60F14A63-68D4-464C-9563-6ED182077B82

Q34187707-737BA097-0900-454C-995B-48B63D4A6277

Q34187707-7505879A-B421-42C7-A079-7B3A77712918

Q34187707-8609D2D8-BEC3-449A-BE4D-5BBB8FEF6633

P2860

Q34187707-09592CB0-45E2-4EDD-B0AF-233425F00054

Q34187707-105E67EC-4553-43EE-AEB6-3C5F6D65BEFA

Q34187707-4234F998-C8FB-4A4E-958D-7892F9647E36

Q34187707-449B8764-46A7-4B18-9979-1C2DBFCDD4DA

Q34187707-5148150B-810A-41D9-BB28-4CCBD746CCE1

Q34187707-5B59DA91-533F-4F1C-A3CC-1B7BABDD3B2A

Q34187707-5C2A0C89-5374-4312-B2B8-5447ADE25C09

Q34187707-667E04B7-EFE4-4709-B71A-202D99F922F8

Q34187707-6974E8D5-8E19-476E-BAD7-EF38C519A50F

Q34187707-6D04FCAA-5BE0-4EFD-954F-D003B1F10A72

P304

Q34187707-BB77A1FF-3791-4CAD-9E16-D80B63A0EBD3

P31

Q34187707-2CD5270C-9FB4-4B01-84E1-8A03F978C214

P356

Q34187707-050C5F2A-0A81-42A8-A11F-A1DC027CAA45

P433

Q34187707-B03DDFA8-9F5C-4839-B88B-53D5D014354F

P478

Q34187707-156705D1-DD3E-4AEC-8523-AFC1913CBC9D

P577

Q34187707-409A539E-0823-4808-8DE3-D61760EAA0BA

P698

Q34187707-80402859-2737-4004-8F1A-3B904752D924

P921

Q34187707-D5EC83EB-05F7-457A-99D3-C02BE8E30576

P932

Q34187707-25D09EA3-BD93-419E-B610-64248C38330B

P356

P1433

Journal of the American Society of Nephrology

P1476

DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

@en

P2093

Caroline E Jennette

http://www.w3.org/2001/XMLSchema#string

Donna Bunch

http://www.w3.org/2001/XMLSchema#string

Elisabeth A Berg

http://www.w3.org/2001/XMLSchema#string

Frank C Arnett

http://www.w3.org/2001/XMLSchema#string

Gloria A Preston

http://www.w3.org/2001/XMLSchema#string

J Charles Jennette

http://www.w3.org/2001/XMLSchema#string

Jiajin Yang

http://www.w3.org/2001/XMLSchema#string

John L Schmitz

http://www.w3.org/2001/XMLSchema#string

Ronald J Falk

http://www.w3.org/2001/XMLSchema#string

Susan L Hogan

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site

Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.

A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach

Wegener's granulomatosis in two sisters

Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis.

Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3.

Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease.

Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts.

ANCA patients have T cells responsive to complementary PR-3 antigen

Wegener's granulomatosis occurring in siblings.

P304

1161-1167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2010101058

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21617122

http://www.w3.org/2001/XMLSchema#string

P921

P932

3103736

http://www.w3.org/2001/XMLSchema#string